{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:39:53Z","timestamp":1791319193371,"version":"4.3.1"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T00:00:00Z","timestamp":1713916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"University Medical Centre Ljubljana","award":["TP20180084"],"award-info":[{"award-number":["TP20180084"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>Primary prevention patients with ischaemic cardiomyopathy and chronic total occlusion of an infarct-related coronary artery (CTO) are at a particularly high risk of implantable cardioverter-defibrillator (ICD) therapy occurrence. The trial was designed to evaluate the efficacy of preventive CTO-related substrate ablation strategy in ischaemic cardiomyopathy patients undergoing primary prevention ICD implantation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results<\/jats:title>\n                  <jats:p>The PREVENTIVE VT study was a prospective, multicentre, randomized trial including ischaemic patients with ejection fraction \u226440%, no documented ventricular arrhythmias (VAs), and evidence of scar related to the coronary CTO. Patients were randomly assigned 1:1 to a preventive substrate ablation before ICD implantation or standard therapy with ICD implantation only. The primary outcome was a composite of appropriate ICD therapy or unplanned hospitalization for VAs. Secondary outcomes included the primary outcome\u2019s components, the incidence of appropriate ICD therapies, cardiac hospitalization, electrical storm, and cardiovascular (CV) mortality. Sixty patients were included in the study. During the mean follow-up of 44.7 \u00b1 20.7 months, the primary outcome occurred in 5 (16.7%) patients undergoing preventive substrate ablation and in 13 (43.3%) patients receiving only ICD [hazard ratio (HR): 0.33; 95% confidence interval (CI): 0.12\u20130.94; P = 0.037]. Patients in the preventive ablation group also had fewer appropriate ICD therapies (P = 0.039) and the electrical storms (Log-rank: P = 0.01). While preventive ablation also reduced cardiac hospitalizations (P = 0.006), it had no significant impact on CV mortality (P = 0.151).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Preventive ablation of the coronary CTO-related substrate in patients undergoing primary ICD implantation is associated with the reduced risk of appropriate ICD therapy or unplanned hospitalization due to VAs.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/europace\/euae109","type":"journal-article","created":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T20:12:55Z","timestamp":1713989575000},"source":"Crossref","is-referenced-by-count":22,"title":["Impact of preventive substrate catheter ablation on implantable cardioverter-defibrillator interventions in patients with ischaemic cardiomyopathy and infarct-related coronary chronic total occlusion"],"prefix":"10.1093","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5029-3989","authenticated-orcid":false,"given":"David","family":"\u017di\u017eek","sequence":"first","affiliation":[{"name":"Cardiology Department, University Medical Centre Ljubljana , Zalo\u0161ka 7, 1000 Ljubljana , Slovenia"},{"name":"Faculty of Medicine, University of Ljubljana , Ljubljana , Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6258-6401","authenticated-orcid":false,"given":"Miha","family":"Mrak","sequence":"additional","affiliation":[{"name":"Cardiology Department, University Medical Centre Ljubljana , Zalo\u0161ka 7, 1000 Ljubljana , Slovenia"},{"name":"Faculty of Medicine, University of Ljubljana , Ljubljana , Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6379-9986","authenticated-orcid":false,"given":"Matev\u017e","family":"Jan","sequence":"additional","affiliation":[{"name":"University Medical Centre Ljubljana, Cardiovascular Surgery Department , Ljubljana , Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3650-5986","authenticated-orcid":false,"given":"Anja","family":"Zupan Me\u017enar","sequence":"additional","affiliation":[{"name":"Cardiology Department, University Medical Centre Ljubljana , Zalo\u0161ka 7, 1000 Ljubljana , Slovenia"},{"name":"Faculty of Medicine, University of Ljubljana , Ljubljana , Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0189-099X","authenticated-orcid":false,"given":"Maja","family":"Ivanovski","sequence":"additional","affiliation":[{"name":"Cardiology Department, University Medical Centre Ljubljana , Zalo\u0161ka 7, 1000 Ljubljana , Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4014-5680","authenticated-orcid":false,"given":"Tadej","family":"\u017dlahti\u010d","sequence":"additional","affiliation":[{"name":"Cardiology Department, University Medical Centre Ljubljana , Zalo\u0161ka 7, 1000 Ljubljana , Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0499-1828","authenticated-orcid":false,"given":"Nina","family":"Kajdi\u010d","sequence":"additional","affiliation":[{"name":"Cardiology Department, University Medical Centre Ljubljana , Zalo\u0161ka 7, 1000 Ljubljana , Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5482-3809","authenticated-orcid":false,"given":"Bor","family":"Antoli\u010d","sequence":"additional","affiliation":[{"name":"Cardiology Department, University Medical Centre Ljubljana , Zalo\u0161ka 7, 1000 Ljubljana , Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luka","family":"Klemen","sequence":"additional","affiliation":[{"name":"Cardiology Department, University Medical Centre Ljubljana , Zalo\u0161ka 7, 1000 Ljubljana , Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0913-1536","authenticated-orcid":false,"given":"Rafael","family":"Skale","sequence":"additional","affiliation":[{"name":"Cardiology Division, General Hospital Celje , Celje , Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jurij","family":"Avramovi\u010d Gregori\u010d","sequence":"additional","affiliation":[{"name":"Cardiology Division, General Hospital Izola , Izola , Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jernej","family":"\u0160tublar","sequence":"additional","affiliation":[{"name":"Cardiology Department, University Medical Centre Ljubljana , Zalo\u0161ka 7, 1000 Ljubljana , Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrej","family":"Pernat","sequence":"additional","affiliation":[{"name":"Cardiology Department, University Medical Centre Ljubljana , Zalo\u0161ka 7, 1000 Ljubljana , Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8789-6046","authenticated-orcid":false,"given":"Matja\u017e","family":"\u0160inkovec","sequence":"additional","affiliation":[{"name":"Cardiology Department, University Medical Centre Ljubljana , Zalo\u0161ka 7, 1000 Ljubljana , Slovenia"},{"name":"Faculty of Medicine, University of Ljubljana , Ljubljana , Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,4,24]]},"reference":[{"key":"2024053111024934100_euae109-B1","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S1099-5129(03)00078-3","article-title":"Implantable cardioverter defibrillator recipients: quality of life in recipients with and without ICD shock delivery: a prospective study","volume":"5","author":"Kamphuis","year":"2003","journal-title":"Europace"},{"key":"2024053111024934100_euae109-B2","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.1161\/01.CIR.0000150390.04704.B7","article-title":"Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator","volume":"110","author":"Moss","year":"2004","journal-title":"Circulation"},{"key":"2024053111024934100_euae109-B3","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1540-8159.2006.00409.x","article-title":"Depression and anxiety status of patients with implantable cardioverter defibrillator and precipitating factors","volume":"29","author":"Bilge","year":"2006","journal-title":"Pacing Clin Electrophysiol"},{"key":"2024053111024934100_euae109-B4","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1056\/NEJMoa1211107","article-title":"Reduction in inappropriate therapy and mortality through ICD programming","volume":"367","author":"Moss","year":"2012","journal-title":"N Engl J Med"},{"key":"2024053111024934100_euae109-B5","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1161\/01.CIR.77.3.589","article-title":"Reentry as a cause of ventricular tachycardia in patients with chronic ischemic heart disease: electrophysiologic and anatomic correlation","volume":"77","author":"de Bakker","year":"1988","journal-title":"Circulation"},{"key":"2024053111024934100_euae109-B6","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1056\/NEJMoa065457","article-title":"Prophylactic catheter ablation for the prevention of defibrillator therapy","volume":"357","author":"Reddy","year":"2007","journal-title":"N Engl J Med"},{"key":"2024053111024934100_euae109-B7","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1016\/j.jacc.2015.10.026","article-title":"Ablation of stable VTs versus substrate ablation in ischemic cardiomyopathy: the VISTA randomized multicenter trial","volume":"66","author":"Di Biase","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2024053111024934100_euae109-B8","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1513614","article-title":"Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs","volume":"37","author":"Sapp","year":"2016","journal-title":"N Engl J Med"},{"key":"2024053111024934100_euae109-B9","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","article-title":"2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"43","author":"Zeppenfeld","year":"2022","journal-title":"Eur Heart J"},{"key":"2024053111024934100_euae109-B10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(09)61755-4","article-title":"Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial","volume":"375","author":"Kuck","year":"2010","journal-title":"Lancet"},{"key":"2024053111024934100_euae109-B11","doi-asserted-by":"crossref","first-page":"e004422","DOI":"10.1161\/CIRCEP.116.004422","article-title":"Impact of substrate modification by catheter ablation on implantable cardioverter defibrillator interventions in patients with unstable ventricular arrhythmias and coronary artery disease: results from the multicenter randomized controlled SMS (Substrate Modification Study)","volume":"10","author":"Kuck","year":"2017","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2024053111024934100_euae109-B12","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1161\/CIRCULATIONAHA.119.043400","article-title":"Preventive or deferred ablation of ventricular tachycardia in patients with ischemic cardiomyopathy and implantable defibrillator (BERLIN VT): a multicenter randomized trial","volume":"141","author":"Willems","year":"2020","journal-title":"Circulation"},{"key":"2024053111024934100_euae109-B13","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1161\/CIRCULATIONAHA.122.059598","article-title":"Does timing of ventricular tachycardia ablation affect prognosis in patients with an implantable cardioverter defibrillator? Results from the multicenter randomized PARTITA trial","volume":"145","author":"Della Bella","year":"2022","journal-title":"Circulation"},{"key":"2024053111024934100_euae109-B14","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.jacc.2022.01.050","article-title":"Substrate ablation vs antiarrhythmic drug therapy for symptomatic ventricular tachycardia","volume":"79","author":"Arenal","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2024053111024934100_euae109-B15","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1161\/CIRCEP.111.968008","article-title":"Ventricular arrhythmias among implantable cardioverter-defibrillator recipients for primary prevention: impact of chronic total coronary occlusion (VACTO Primary Study)","volume":"5","author":"Nombela-Franco","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2024053111024934100_euae109-B16","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.jcin.2017.02.008","article-title":"Impact of chronic total coronary occlusion on recurrence of ventricular arrhythmias in ischemic secondary prevention implantable cardioverter-defibrillator recipients (VACTO Secondary Study): insights from coronary angiogram and electrogram analysis","volume":"10","author":"Nombela-Franco","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"2024053111024934100_euae109-B17","doi-asserted-by":"crossref","first-page":"e008609","DOI":"10.1161\/JAHA.118.008609","article-title":"Evaluation of the impact of a chronic total coronary occlusion on ventricular arrhythmias and long-term mortality in patients with ischemic cardiomyopathy and an implantable cardioverter-defibrillator (the eCTOpy-in-ICD study)","volume":"7","author":"van Dongen","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"2024053111024934100_euae109-B18","first-page":"267","article-title":"Chronic total occlusion of an infarct-related artery: a new predictor of ventricular arrhythmias in primary prevention implantable cardioverter defibrillator patients","volume":"19","author":"Di Marco","year":"2017","journal-title":"Europace"},{"key":"2024053111024934100_euae109-B19","first-page":"1153","article-title":"Prognostic impact of chronic total coronary occlusion on long-term outcomes in implantable cardioverter-defibrillator recipients with ischaemic heart disease","volume":"19","author":"Nishikawa","year":"2017","journal-title":"Europace"},{"key":"2024053111024934100_euae109-B20","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1056\/NEJMoa2206606","article-title":"Percutaneous revascularization for ischemic left ventricular dysfunction","volume":"387","author":"Perera","year":"2022","journal-title":"N Engl J Med"},{"key":"2024053111024934100_euae109-B21","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1016\/j.hrthm.2015.11.018","article-title":"2015 HRS\/EHRA\/APHRS\/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing","volume":"13","author":"Wilkoff","year":"2016","journal-title":"Heart Rhythm"},{"key":"2024053111024934100_euae109-B22","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/j.jacc.2017.02.044","article-title":"Early mortality after catheter ablation of ventricular tachycardia in patients with structural heart disease","volume":"69","author":"Santangeli","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2024053111024934100_euae109-B23","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/j.hrthm.2015.05.036","article-title":"Freedom from recurrent ventricular tachycardia after catheter ablation is associated with improved survival in patients with structural heart disease: an international VT Ablation Center Collaborative Group study","volume":"12","author":"Tung","year":"2015","journal-title":"Heart Rhythm"},{"key":"2024053111024934100_euae109-B24","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1093\/europace\/eut050","article-title":"Prophylactic catheter ablation for induced monomorphic ventricular tachycardia in patients with implantable cardioverter defibrillators as primary prevention","volume":"15","author":"Hayashi","year":"2013","journal-title":"Europace"},{"key":"2024053111024934100_euae109-B25","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1093\/europace\/euab328","article-title":"Ventricular tachycardia characteristics and outcomes with catheter ablation vs. antiarrhythmic therapy: insights from the VANISH trial","volume":"24","author":"Deyell","year":"2022","journal-title":"Europace"},{"key":"2024053111024934100_euae109-B26","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1016\/j.jacc.2018.08.2162","article-title":"Ejection fraction pros and cons: JACC state-of-the-art review","volume":"72","author":"Marwick","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2024053111024934100_euae109-B27","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.jacep.2020.07.028","article-title":"Safety and outcomes of ventricular tachycardia substrate ablation during sinus rhythm: a prospective multicenter registry","volume":"6","author":"Fernandez-Armenta","year":"2020","journal-title":"JACC Clin Electrophysiol"},{"key":"2024053111024934100_euae109-B28","doi-asserted-by":"crossref","first-page":"e006857","DOI":"10.1161\/CIRCEP.118.006857","article-title":"Does ventricular tachycardia ablation targeting local abnormal ventricular activity elimination reduce ventricular fibrillation incidence?","volume":"12","author":"Kitamura","year":"2019","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2024053111024934100_euae109-B29","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/jce.12622","article-title":"Impact of a chronic total occlusion in an infarct-related artery on the long-term outcome of ventricular tachycardia ablation","volume":"26","author":"Di Marco","year":"2015","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2024053111024934100_euae109-B30","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jacep.2021.12.011","article-title":"Endocardial scar-homogenization with vs without epicardial ablation in VT patients with ischemic cardiomyopathy","volume":"8","author":"Mohanty","year":"2022","journal-title":"JACC Clin Electrophysiol"},{"key":"2024053111024934100_euae109-B31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jacep.2018.08.010","article-title":"Combined endocardial-epicardial versus endocardial catheter ablation alone for ventricular tachycardia in structural heart disease: a systematic review and meta-analysis","volume":"5","author":"Romero","year":"2019","journal-title":"JACC Clin Electrophysiol"},{"key":"2024053111024934100_euae109-B32","doi-asserted-by":"crossref","first-page":"euae030","DOI":"10.1093\/europace\/euae030","article-title":"Management of ventricular tachycardias: insights on centre settings, procedural workflow, endpoints, and implementation of guidelines\u2014results from an EHRA survey","volume":"26","author":"Sultan","year":"2024","journal-title":"Europace"}],"container-title":["Europace"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/europace\/advance-article-pdf\/doi\/10.1093\/europace\/euae109\/57322116\/euae109.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/26\/5\/euae109\/58012976\/euae109.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/26\/5\/euae109\/58012976\/euae109.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T20:11:19Z","timestamp":1717186279000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/europace\/article\/doi\/10.1093\/europace\/euae109\/7657748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,24]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5,2]]}},"URL":"https:\/\/doi.org\/10.1093\/europace\/euae109","relation":{},"ISSN":["1099-5129","1532-2092"],"issn-type":[{"value":"1099-5129","type":"print"},{"value":"1532-2092","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,5]]},"published":{"date-parts":[[2024,4,24]]},"article-number":"euae109"}}